Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.33
NYSE:MCK's Cash-to-Debt is ranked lower than
75% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.74 vs. NYSE:MCK: 0.33 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:MCK' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.1  Med: 0.5 Max: 2.16
Current: 0.33
0.1
2.16
Equity-to-Asset 0.18
NYSE:MCK's Equity-to-Asset is ranked lower than
96% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. NYSE:MCK: 0.18 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:MCK' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.27 Max: 0.35
Current: 0.18
0.15
0.35
Interest Coverage 23.08
NYSE:MCK's Interest Coverage is ranked lower than
53% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.37 vs. NYSE:MCK: 23.08 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:MCK' s Interest Coverage Range Over the Past 10 Years
Min: 7.94  Med: 9.12 Max: 23.08
Current: 23.08
7.94
23.08
Piotroski F-Score: 4
Altman Z-Score: 4.38
Beneish M-Score: -2.30
WACC vs ROIC
8.32%
38.92%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 3.58
NYSE:MCK's Operating Margin % is ranked lower than
66% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.78 vs. NYSE:MCK: 3.58 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:MCK' s Operating Margin % Range Over the Past 10 Years
Min: 1.12  Med: 1.76 Max: 3.58
Current: 3.58
1.12
3.58
Net Margin % 2.55
NYSE:MCK's Net Margin % is ranked lower than
70% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.65 vs. NYSE:MCK: 2.55 )
Ranked among companies with meaningful Net Margin % only.
NYSE:MCK' s Net Margin % Range Over the Past 10 Years
Min: 0.77  Med: 1.08 Max: 2.55
Current: 2.55
0.77
2.55
ROE % 54.62
NYSE:MCK's ROE % is ranked higher than
90% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.33 vs. NYSE:MCK: 54.62 )
Ranked among companies with meaningful ROE % only.
NYSE:MCK' s ROE % Range Over the Past 10 Years
Min: 13.37  Med: 18.14 Max: 54.62
Current: 54.62
13.37
54.62
ROA % 8.69
NYSE:MCK's ROA % is ranked lower than
55% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.93 vs. NYSE:MCK: 8.69 )
Ranked among companies with meaningful ROA % only.
NYSE:MCK' s ROA % Range Over the Past 10 Years
Min: 2.79  Med: 4.08 Max: 8.69
Current: 8.69
2.79
8.69
ROC (Joel Greenblatt) % 232.99
NYSE:MCK's ROC (Joel Greenblatt) % is ranked higher than
88% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.27 vs. NYSE:MCK: 232.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:MCK' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 63.18  Med: 122.48 Max: 261.54
Current: 232.99
63.18
261.54
3-Year Revenue Growth Rate 14.70
NYSE:MCK's 3-Year Revenue Growth Rate is ranked higher than
82% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.40 vs. NYSE:MCK: 14.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:MCK' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13.6  Med: 11.5 Max: 23.7
Current: 14.7
-13.6
23.7
3-Year EBITDA Growth Rate 38.30
NYSE:MCK's 3-Year EBITDA Growth Rate is ranked higher than
64% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.40 vs. NYSE:MCK: 38.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:MCK' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -52.7  Med: 11.75 Max: 171.6
Current: 38.3
-52.7
171.6
3-Year EPS without NRI Growth Rate 56.40
NYSE:MCK's 3-Year EPS without NRI Growth Rate is ranked higher than
67% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.30 vs. NYSE:MCK: 56.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:MCK' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -44.5  Med: 13.3 Max: 87.1
Current: 56.4
-44.5
87.1
GuruFocus has detected 1 Warning Sign with McKesson Corp $NYSE:MCK.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:MCK's 30-Y Financials

Financials (Next Earnings Date: 2017-08-18 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

MCK Guru Trades in Q2 2016

Tom Gayner 9,100 sh (New)
Ronald Muhlenkamp 46,183 sh (New)
Jim Simons 97,400 sh (New)
David Dreman 5,004 sh (New)
Steven Cohen 175,700 sh (+1809.78%)
Ray Dalio 33,359 sh (+156.61%)
Diamond Hill Capital 1,382 sh (+0.51%)
Vanguard Health Care Fund 7,165,280 sh (unchged)
Wallace Weitz 57,675 sh (unchged)
Pioneer Investments Sold Out
Dodge & Cox Sold Out
Larry Robbins Sold Out
Paul Tudor Jones Sold Out
John Buckingham 22,267 sh (-0.12%)
Arnold Van Den Berg 68,913 sh (-1.79%)
Scott Black 9,047 sh (-2.86%)
John Paulson 60,500 sh (-3.20%)
First Pacific Advisors 85,300 sh (-5.48%)
Charles Brandes 39,287 sh (-8.49%)
Manning & Napier Advisors, Inc 36,300 sh (-15.35%)
Jerome Dodson 40,000 sh (-50.00%)
Joel Greenblatt 181,378 sh (-50.61%)
Mario Gabelli 5,000 sh (-58.57%)
» More
Q3 2016

MCK Guru Trades in Q3 2016

Paul Tudor Jones 9,323 sh (New)
Eaton Vance Worldwide Health Sciences Fund 193,108 sh (New)
Jim Simons 758,300 sh (+678.54%)
Charles Brandes 55,134 sh (+40.34%)
Joel Greenblatt 235,225 sh (+29.69%)
Manning & Napier Advisors, Inc 45,250 sh (+24.66%)
Ray Dalio 41,359 sh (+23.98%)
John Paulson 67,000 sh (+10.74%)
Wallace Weitz 58,080 sh (+0.70%)
Jerome Dodson 40,000 sh (unchged)
Vanguard Health Care Fund 7,165,280 sh (unchged)
Tom Gayner 9,100 sh (unchged)
David Dreman 5,004 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Steven Cohen Sold Out
Scott Black 9,035 sh (-0.13%)
John Buckingham 22,140 sh (-0.57%)
Ronald Muhlenkamp 45,753 sh (-0.93%)
Arnold Van Den Berg 67,944 sh (-1.41%)
Diamond Hill Capital 1,360 sh (-1.59%)
First Pacific Advisors 83,080 sh (-2.60%)
» More
Q4 2016

MCK Guru Trades in Q4 2016

Richard Pzena 186,289 sh (New)
Jana Partners 386,868 sh (New)
Steven Cohen 43,100 sh (New)
Seth Klarman 1,000,000 sh (New)
David Tepper 275,000 sh (New)
Larry Robbins 683,516 sh (New)
Charles Brandes 1,045,486 sh (+1796.26%)
Diamond Hill Capital 21,280 sh (+1464.71%)
Jerome Dodson 119,000 sh (+197.50%)
Paul Tudor Jones 26,546 sh (+184.74%)
Ray Dalio 67,759 sh (+63.83%)
Ronald Muhlenkamp 71,767 sh (+56.86%)
Joel Greenblatt 277,057 sh (+17.78%)
Vanguard Health Care Fund 8,218,500 sh (+14.70%)
Mario Gabelli 5,000 sh (unchged)
Tom Gayner 9,100 sh (unchged)
Jim Simons Sold Out
Wallace Weitz Sold Out
John Paulson Sold Out
Eaton Vance Worldwide Health Sciences Fund Sold Out
Scott Black 8,813 sh (-2.46%)
Arnold Van Den Berg 66,107 sh (-2.70%)
John Buckingham 21,226 sh (-4.13%)
Manning & Napier Advisors, Inc 38,800 sh (-14.25%)
David Dreman 3,925 sh (-21.56%)
First Pacific Advisors 57,200 sh (-31.15%)
» More
Q1 2017

MCK Guru Trades in Q1 2017

George Soros 1,400 sh (New)
Richard Pzena 2,077,104 sh (+1014.99%)
Steven Cohen 358,500 sh (+731.79%)
Scott Black 15,006 sh (+70.27%)
Jerome Dodson 168,000 sh (+41.18%)
Larry Robbins 917,776 sh (+34.27%)
Arnold Van Den Berg 80,140 sh (+21.23%)
Charles Brandes 1,121,845 sh (+7.30%)
John Buckingham 21,254 sh (+0.13%)
Tom Gayner 9,100 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
David Dreman 3,925 sh (unchged)
Seth Klarman 1,000,000 sh (unchged)
Jana Partners Sold Out
Diamond Hill Capital 21,251 sh (-0.14%)
Ronald Muhlenkamp 71,430 sh (-0.47%)
Vanguard Health Care Fund 8,002,819 sh (-2.62%)
First Pacific Advisors 48,300 sh (-15.56%)
Ray Dalio 57,101 sh (-15.73%)
Manning & Napier Advisors, Inc 26,355 sh (-32.07%)
Paul Tudor Jones 15,721 sh (-40.78%)
Joel Greenblatt 129,666 sh (-53.20%)
David Tepper 100,000 sh (-63.64%)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)